SCHEMBL6208617

SCHEMBL6208617

CS(=O)(=O)OCC1CN(c2ccc3c(c2)CCCCN3C(=O)OCc2ccccc2)C(=O)O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TMEM97 Q5BJF2 11/20 0.40
SIGMAR1 Q99720 11/20 0.40
GRM2 Q14416 2/20 0.39
F10 P00742 3/20 0.38
MGAT2 Q10469 1/20 0.38
HTR1A P08908 2/20 0.37
ADRA2A P08913 2/20 0.37
ADRA2B P18089 2/20 0.37
HRH2 P25021 2/20 0.37
HTR2A P28223 2/20 0.37
HTR2C P28335 2/20 0.37
HRH1 P35367 2/20 0.37
HTR2B P41595 2/20 0.37
HRH3 Q9Y5N1 2/20 0.37
ADRA2C P18825 1/20 0.37
DRD1 P21728 1/20 0.37
HTR1B P28222 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6191207 0.88 NPC1 (0.47) NPC1RAB9AL3MBTL1TMEM97SIGMAR1
SCHEMBL6291326 0.88 NPC1 (0.47) NPC1RAB9AL3MBTL1TMEM97SIGMAR1
SCHEMBL6214916 0.88 MAOB (0.40) GRM2F10
SCHEMBL6190889 0.87 NPC1 (0.46) NPC1RAB9AL3MBTL1TMEM97SIGMAR1
SCHEMBL6192982 0.85 MAOA (0.51) NPC1RAB9AL3MBTL1TMEM97SIGMAR1
SCHEMBL6292472 0.82 NPC1 (0.44) NPC1RAB9AL3MBTL1TMEM97SIGMAR1
SCHEMBL6961334 0.81 GRM2 (0.40) TMEM97SIGMAR1GRM2HTR1AADRA2A
SCHEMBL7597985 0.81 GRM2 (0.38) TMEM97SIGMAR1GRM2HTR1AADRA2A
SCHEMBL5326969 0.80 MAOB (0.51) NPC1F10ALDH1A1HPGD
SCHEMBL6399072 0.77 CALML3 (0.41) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1594494-A1 OXAZOLIDINONE DERIVATIVES N-SUBSTITUTED BY A BICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS Warner-Lambert Company LLC (US) 2005-11-16 EP disclosed
US-20040224939-A1 Antibacterial agents CHUPAK LOUIS S (US) 2004-11-11 US disclosed
WO-2004069244-A1 OXAZOLIDINONE DERIVATIVES N-SUBSTITUTED BY A BICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY LLC (US) 2004-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040224939-A1 Antibacterial agents MRPL21, RPN2, FBL NPC1 575/4885RAB9A 707/4885L3MBTL1 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.